Jim Atherton

Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.

Jean S. Beebe, Jitesh P. Jani, Elisabeth Knauth et al. · PubMed · 2003 · 128 citations

Cancer Therapy, Pharmacological Characterization, Tumor Biology +21

Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites

Abdul Mutlib, Wing Lam, Jim Atherton et al. · Rapid Communications in Mass Spectrometry · 2005 · 76 citations

Metabolomic Profiling, Gas Chromatography, Bioanalysis +18

Characterization of HKI-272 Covalent Binding to Human Serum Albumin

Jianyao Wang, Xiao Xian Li-Chan, Jim Atherton et al. · Drug Metabolism and Disposition · 2010 · 60 citations

Identification of Potential Genomic Biomarkers of Hepatotoxicity Caused by Reactive Metabolites of <i>N</i> -Methylformamide:  Application of Stable Isotope Labeled Compounds in Toxicogenomic Studies

Abdul Mutlib, Ping Jiang, Jim Atherton et al. · Chemical Research in Toxicology · 2006 · 20 citations